Nakamura Masanori, Uzuka Takeshi, Sato Hiroshi, Kondo Mayo, Sakata Junichi, Kodama Fumihiro, Murai Daisuke, Komatsu Hiroshi, Makino Takao, Kohya Tetsuro
Department of Cardiovascular Surgery, Sapporo City General Hospital, North 11 West 13 Chuo-ku, Sapporo, Hokkaido, 060-8604, Japan.
Departments of Infection Control, Sapporo City General Hospital, Sapporo, Japan.
Gen Thorac Cardiovasc Surg. 2019 May;67(5):427-435. doi: 10.1007/s11748-018-1040-9. Epub 2018 Nov 27.
We investigated the hypothesis that early surgery for infective endocarditis (IE) attenuates the rate of death or embolic events and does not increase the rate of relapse or postoperative valvular dysfunction (PVD) at 6 months.
21 consecutive patients who underwent surgical treatment of IE were prospectively included. We assessed 6-month postoperative clinical outcomes by comparing early surgery (Group E, surgery within 72 h) and conventional treatment (Group C). Nine patients (43%) were assigned to Group E based on a combination of preoperative evaluation parameters, including the findings of cerebral magnetic resonance imaging (MRI), which was performed in all patients with left-sided IE.
Six surgical plans (5 advancements and 1 postponement) were modified by routine MRI. Although preoperative echocardiography did not confirm all annular invasions, the rate of periannular infection, which was treated by pericardial annular patch plasty (56%) in patients with native-valve IE, was higher in Group E than C (P = 0.006). Early surgery based on MRI findings resulted in no postoperative embolic events or cerebral bleeding. The 6-month mortality rate was 0% in both groups, although the calculated 6-month IE mortality rate was 49.2 ± 25% and 28.8 ± 18%, respectively. No recurrence of IE or PVD occurred in Group E. The 6-month rate of freedom from composite events was 100% in Group E.
Aggressive treatment (periannular resection and disuse of a prosthetic annuloplasty ring) and optimal antibiotic therapy based on intraoperative microorganisms, even in patients who underwent early surgery, reduced the 6-month relapse and PVD rates.
我们研究了以下假设,即感染性心内膜炎(IE)的早期手术可降低死亡或栓塞事件的发生率,且不会增加6个月时的复发率或术后瓣膜功能障碍(PVD)发生率。
前瞻性纳入21例接受IE手术治疗的连续患者。我们通过比较早期手术(E组,72小时内手术)和传统治疗(C组)来评估术后6个月的临床结局。根据术前评估参数组合,将9例患者(43%)分配至E组,术前评估参数包括对所有左侧IE患者进行的脑磁共振成像(MRI)检查结果。
常规MRI修改了6个手术方案(5个提前和1个推迟)。尽管术前超声心动图未确认所有瓣环侵犯情况,但E组自体瓣膜IE患者中采用心包瓣环补片成形术治疗的瓣周感染率(56%)高于C组(P = 0.006)。基于MRI检查结果的早期手术未导致术后栓塞事件或脑出血。两组6个月死亡率均为0%,尽管计算得出的6个月IE死亡率分别为49.2±25%和28.8±18%。E组未发生IE复发或PVD。E组6个月复合事件无发生率为100%。
积极治疗(瓣周切除和不使用人工瓣环成形环)以及基于术中微生物的最佳抗生素治疗,即使对于接受早期手术的患者,也可降低6个月的复发率和PVD发生率。